Bibliographic Details
| Title: |
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer. |
| Authors: |
Hortobagyi, G. N.1 ghortoba@mdanderson.org, Stemmer, S. M.2, Burris, H. A.3, Yap, Y.-S.4, Sonke, G. S.5, Paluch-Shimon, S.6, Campone, M.7, Blackwell, K. L.8, André, F.9, Winer, E. P.10, Janni, W.11, Verma, S.12, Conte, P.13, Arteaga, C. L.14, Cameron, D. A.15, Petrakova, K.16, Hart, L. L.17, Villanueva, C.18, Chan, A.19, Jakobsen, E.20 |
| Source: |
New England Journal of Medicine. 11/3/2016, Vol. 375 Issue 18, p1738-1748. 11p. |
| Database: |
Academic Search Ultimate |
